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Background: Patients with chronic heart failure (CHF) suffer from ventilatory abnormalities.
This study examined the effects of interval exercise training on the respiratory drive in CHF
patients.
Methods: Forty-six clinically stable CHF patients (38 males/8 women, mean age Z 53  11
years) participated in an exercise rehabilitation program (ERP) 3 times/week, for 12 weeks
by interval training modality with or without the addition of resistance training. All patients
underwent symptom-limited cardiopulmonary exercise testing (CPET), and measurements of
mouth occlusion pressure at 100 ms (P0.1) and maximum inspiratory muscle strength (PImax)
before and after ERP. Respiratory drive was estimated by mouth occlusion pressure P0.1 and
P0.1/PImax ratio at rest, and the ventilatory pattern by resting mean inspiratory flow (VT/TI)
and by VT/TI at identical CPET workloads, before and after ERP. We also studied a control
non exercising group of 11 patients (8 men and 3 women).
Results: P0.1 at rest decreased from 3.04 1.52 to 2.62 0.9 cmH2O (pZ 0.015), P0.1/PImax % at
rest from 4.56  3.73 to 3.69  2.03 (p Z 0.006), resting VT/T I from 0.44  0.10 to
0.41  0.10 l/s (pZ 0.014), and VT/TI at identical work rate from 2.13  0.59 to 1.93  0.58 l/s
(pZ 0.001) after ERP. VO2 at peak exercise increased from 16.3  4.8 to 18.5  5.3 ml/kg/min
(p < 0.001) in the exercise group. No improvement was noted in the control group.0 7201918/6973036448; fax: þ30 210 7244941.
(S. Nanas).
0 Published by Elsevier Ltd.
1558 A. Tasoulis et al.Conclusions: ERP by interval training improves the respiratory drive and ventilatory pattern at rest
and during exercise in CHF patients.
ª 2010 Published by Elsevier Ltd.Introduction
Dyspnea and fatigue are the main disease manifestations,
which limit the physical activity and lower the quality of life
of patients suffering from chronic heart failure (CHF).1e3
Several central or peripheral pathophysiological mecha-
nisms, such as low cardiac output, pulmonary hypertension,4
increased pulmonary capillary wedge pressure during exer-
cise, and peripheral myopathy,5 contribute to exercise
intolerance in CHF. Respiratory abnormalities, including
restrictive and obstructive breathing patterns,6e8 decreased
lung compliance,9 decreased diffusion capacity,10 hyper-
ventilation,11 ventilationeperfusion mismatch,12 bronchial
hyper-responsiveness,13 respiratory muscle weakness14,15
and decreased inspiratory capacity16 have also been
observed in these patients. The respiratory drive in patients
suffering from CHF is significantly higher than in normal
subjects, indicating the exertion of a greater respiratory
effort, associated with an increased dyspnea score.17
Exercise by continuous aerobic training has been described
to improve functional capacity, quality of life and clinical
outcomesofCHFpatients.18e20Recentdata showthat interval
aerobic training can be a valid alternativemodality of training
that improves maximal oxygen uptake even in CHF patients
with severely impaired cardiovascular function.21e23 Recent
studies have also suggested that resistance training in
combination with aerobic training induces beneficial effects
in aerobic capacity, muscle strength and peripheral endo-
thelial function, with neuro-modulation and anti-
inflammatory effects in these patients.24,25
Our hypothesis was that interval aerobic training alone
or with the addition of resistance training would reverse
respiratory drive abnormalities in CHF patients.
We therefore, prospectively examined the effects of
a 12-week, hospital-based, supervised exercise rehabilita-
tion program (ERP) on CHF patients’ respiratory drive.
Materials and methods
Patients of our heart failure clinic presenting with stable CHF,
NYHA functional class  III, left ventricular ejection fraction
(LVEF) less than 50%were referred to our rehabilitation center
in order to participate in a non hospital based rehabilitation
program. The patients had no need for hospitalization and
theirmedical treatmentwasoptimizedand stable forat least 2
months including beta-blockers, angiotensin converting
enzyme inhibitors, diuretics, nitrates, spironolactone, amio-
darone and digoxin. The diagnosis of CHFwas based on clinical
evaluation and laboratory testing, using non-invasive and
invasive procedures that included electrocardiogram, chest
roentgenogram, echocardiogram, right heart catheterization,
radionuclide ventriculography, coronary angiography and
myocardial biopsy, as clinically indicated. Patients were
excluded if symptom-limitedcardiopulmonaryexercise testing
(CPET) performed according to the American ThoracicSociety/American College of Chest Physicians Statement on
CPETwas contraindicated26 and if they presented with severe
COPD or severe valvular disease. 69 participated in final
randomization. 23 were dropped out after randomization due
to hospitalization for respiratory infections (3 patients), heart
failure decompensation (2 patients) and inability due to
personal reasons to follow the time table of the program or
orthopedic related problems (18 patients).
The baseline characteristics of the 46 (38 men and 8
women) CHF patients are listed in Table 1. A history of type II
diabetes mellitus treated with oral anti-diabetics was eli-
cited in 3 patients. The study was designed as a randomized
controlled parallel two-group study. The patients enrolled in
the study were randomly assigned, according to VO2 peak
(cut-off 16 ml/kg/min) and age (cut-off 50 years old), to
interval aerobic or combined interval aerobic plus strength
exercise training program, so that the two groups were
stratified, and attended a three-month rehabilitation
program. The primary end point of the study was to investi-
gate the effect of exercise training on respiratory drive and
breathing pattern. The study also aimed at revealing the
differences, if such exist, between the two exercise modes.
The investigator performing the CPET and respiratory drive
measurements was not aware of the patients’ specific
assignment to the aerobic or combined group.
All patients underwent maximal symptom-limited cardio-
pulmonary exercise testing (CPET), before the beginning and
after completion of the program. No significant differences
existed among the groups in respect to age, gender, NYHA
class, CHF etiology, LVEF or medical treatment.
Agroupof11patients (8menand3women)presentingwith
stable CHF, matched for age (53  11 years), BMI (26  4 kg/
m2), and exercise capacity was also included in the study as
a control group that did not participate in the rehabilitation
program. The control group was a non randomized, non
parallel group, that consisted of patients that presented with
stable CHF, NYHA functional class  III, left ventricular ejec-
tion fraction (LVEF) less than 50% with no need for hospitali-
zation and optimal medical treatment, who were referred to
our rehabilitation center and were selected prospectively.
The diagnosis of CHF was based on clinical evaluation and
laboratory testing as in the exercise group. These patients did
not wish to participate in the rehabilitation program even
though theywere encouraged to do so, aswere the patients in
the exercise group. They were given standard instructions for
their daily activity, encouraged to walk 3e5 times per week
for 20e30 min and they had the same clinical observation as
the patients randomized to our study.
This study was approved by our Institutional Bioethics
Committee, and written informed consent was obtained
from all patients.
Exercise prescription
Exercise CHF group underwent aerobic exercise training,
with or without strength training on electromagnetically
Table 1 Baseline characteristics of 46 study patients.
All patients Aerobic group Combined group
Age, years 53  11 53  11 53  12
Men/women 38/8 19/2 19/6
Body mass index, kg/m2 27.2  4.6 27.0  4.7 27.4  4.6
New York heart association functional class
I 13 6 7
II 26 13 13
III 7 2 5
Left ventricular ejection fraction, % 34.9  10.5 34.1  11 35.6  10.3
Underlying heart disease
Cardiomyopathy
Dilated 27 11 16
Ischemic 16 8 8
Valvular 3 2 1
Drug regimens
Angiotensin-converting enzyme inhibitors 37 17 20
b-Adrenergic blockers 41 19 22
Diuretics 42 20 22
Spironolactone 26 12 14
Digoxin 14 6 8
Nitrates 2 2 e
Amiodarone 16 7 9
Values are means  SD or numbers of observations.
Respiratory drive and interval training in CHF 1559braked cycle ergometers (Cateye Ergociser, EC1600;
Tokyo, Japan) 3 times weekly, for 12 weeks. Any missed
sessions were added to the end of the program, so that
the 36 sessions were completed. Patients assigned to
aerobic training (n Z 21) exercised at a 50% of baseline
Steep Ramp Test (SRT) (which was performed on
a different day from the CPET) alternating 30 s of exercise
with 60 s of rest for 40 min per session.22 The training
intensity was adjusted every 6 sessions according to a new
SRT. The patients assigned to combined training (n Z 25)
exercised at a 50% of baseline SRT, alternating 30 s of
exercise with 60 s of rest for 20 min per session and also
attended 20 min strength training, so that the total time
of exercise was the same in both groups. Strength training
included training of quadriceps, at 55e65% of 2 resistant
maximum (2RM), training of ham strings, at 55e65% of 2RM
minus 1 kg, training of the biceps and muscles of the
shoulder zone, at an intensity level defined by the weights
the patient could lift up to 10 repetitions. Each muscle
group was trained at each limb separately with a pause of
30 s between the groups. The exercise sessions were
supervised by physicians, exercise physiologists and
physical therapists, including continuous monitoring of
the electrocardiogram and peripheral oxygen saturation,
regular blood pressure measurements, and Borg scale
score assessment.
Cardiopulmonary exercise testing
All patients performed a symptom-limited, ramp-incre-
mental CPET on an electromagnetically braked Ergoline 800
cycle ergometer (SensorMedics, Anaheim, CA) before and
after the completion of the program. In order to reach test
duration of 8e12 min, the individual increments in workloadwere calculated, using the equation published by Hansen
et al.27 Gas exchange was measured with the patient
breathing through a low resistance valve, with the nose
clamped, using amodelVmax 229D instrument (SensorMedics)
calibrated with a known gas mixture before each test.
Breath-by-breath oxygen uptake (VO2), carbon dioxide
output (VCO2) and ventilation (VE) were measured with the
on-line system. All measurements were recorded for 2min at
rest, during unloaded pedaling for 3 min before exercise,
throughout exercise, and during the first 5 min of recovery.
Baseline VO2 was the average of measurements made at rest
for 2 min. Peripheral O2 saturation was monitored continu-
ously by pulse oxymetry. Heart rate and rhythm were moni-
tored by a MAX 1, 12-lead electrocardiographic system
(Marquette Electronics, Milwaukee, WI) and blood pressure
was measured every 2 min with a mercury sphygmomanom-
eter. All patients were verbally encouraged to exercise to
intolerable leg fatigue or dyspnea.
Cardiopulmonary measurements
The gas exchange measurements were used to calculate
VO2 at peak exercise (VO2p) and at the anaerobic threshold,
and the ventilatory equivalent of VCO2 (VE/VCO2) slope
between exercise onset and anaerobic threshold. Peak VO2
was calculated as the average of measurements made for
20 s immediately before the end of exercise. The anaerobic
threshold was determined using the V-slope technique,28
and the result was confirmed graphically from a plot of
ventilatory equivalent for oxygen (VE/VO2) and carbon
dioxide (VE/VCO2) against time. The ventilatory response to
exercise was calculated by linear regression as the slope of
VE vs. VCO2 from the beginning of exercise to anaerobic
threshold, when the relationship is linear.29 In order to
1560 A. Tasoulis et al.examine VO2 kinetics during the early recovery phase, the
first-degree slope of VO2 for the first minute of recovery
(VO2/t-slope) was calculated.
29 Peak work rate was defined
as the highest workload achieved and maintained for 30 s,
at a 50 rpm pedaling rate.
Pulmonary function tests
Spirometry
After familiarization of the patient with the laboratory
environment, measurements of forced vital capacity (FVC)
and forced expiratory volume at 1 s (FEV1) were made
in the sitting position with a closed-circuit spirometer
(SensorMedics) as recommended by the American Thoracic
Society. The measurements were made before and
repeated after ERP.30
Maximal inspiratory pressure
In all patients, the maximal inspiratory pressure (PImax) was
measured at rest, using a Vmax 229 system for pulmonary
and metabolic tests (SensorMedics), by a method similar to
that described by Black and Hyatt.31 For the measurement
of PImax, each patient was instructed to exhale to the
residual volume, and then produce a maximal inspiratory
effort through a closed mouthpiece. The highest peak
pressure reached during 2 (out of at least 3) attempts that
differed by <5% was averaged and retained for analysis. All
tests were performed before and after ERP.
Respiratory drive
Measurements of the mouth occlusion pressure (P0.1) were
made 100 ms after the onset of inspiration at rest. P0.1 was
the inspiratory pressure developed 100 ms after closure of
a valve at the level of functional residual capacity, at rest
(Vmax 229, SensorMedics). After 4 calm breaths with constant
functional residual capacity (FRC) the level of FRC was
detected. Then the valve was randomly closed, to minimize
the likelihood of a deliberate respiratory effort exerted by
the patient against the valve. The measurement was
repeated 6e8 times, and P0.1 was the average of 4 measure-
ments that differed by <5%.32,33 P0.1 was expressed as anTable 2 Respiratory drive and breathing pattern indices before
Exercise rehabilitation p
At rest
Before After
P0.1 (cmH2O) 3.04  1.52 2.62 
P0.1/PImax % 4.56  3.73 3.69 
Mean inspiratory flow (l/s) 0.44  0.10 0.41 
Respiratory cycle (%) 43.9  6.1 45.9 
Breathing frequency (breath/min) 19.5  4.4 19.6 
Tidal volume (l) 0.60  0.11 0.57 
Minute ventilation (l/min) 11.4  2.8 11.1 
Partial pressure of end-tidal carbon
dioxide (mmHg)
34.3  4.5 35.4 
Values are means  SD.
P0.1: mouth occlusion pressure, 100 ms after the onset of inspiration, Pabsolute value (cmH2O), and as a percentage of PImax (P0.1/
PImax%), to normalize its measurement for individual differ-
ences in inspiratory muscle strength. Mean inspiratory flow
(VT/TI) and end-tidal carbon dioxide (PETCO2), VE, VT,
breathing frequency (fb), inspiratory time (TI), total respi-
ratory time (TTot), and respiratory cycle (TI/TTot), were
calculated at rest and breath-by-breath during exercise.
Statistical analysis
All continuous variables are presented as means  SD. For
baseline characteristics, means of continuous variables
were compared by paired Student’s t-test, and categorical
variables by chi-square test. Cardiopulmonary measure-
ments made at baseline and after the completion of the
exercise program or at follow up for the control group were
compared by paired-samples t-test or Wilcoxon’s signed-
rank test, as appropriate. Comparison between groups
was made by repeated measures analysis. The level of
significance was set at <0.05.
Results
After completion of the ERP, mean P0.1, P0.1/PImax, and VT/TI
at rest, were lower than before ERP (Table 2, Figs. 1a and b,
2a). In contrast, a significant increase in TI/TTot was
observed after ERP (Table 2). There were no statistically
significant differences after ERP in mean fb, VT, VE, and
PETCO2 at rest (Table 2). We compared, in each patient, the
indices of ventilatory pattern at peak workload before ERP
with those measured at the same workload after ERP. Mean
VT/TI, fb, VE and TI/TTot decreased and PETCO2 increased
(Figs. 2b, 3). VT did not change significantly (Table 2). VO2 at
peak exercise increased (16.3  4.8 vs. 18.5  5.3 ml/kg/
min, p < 0.001 and 1.31  0.43 vs. 1.49  0.51 L/min,
p < 0.001 for the whole exercise group, 16.4  4.1 vs.
17.8  4.6 ml/kg/min, p < 0.006 and 1.34  0.36 vs.
1.43  0.34 L/min, pZ 0.022 for aerobic group, 16.2  5.3
vs. 19.1  5.8, p < 0.001 and 1.28  0.49 vs. 1.54  0.62 L/
min, p< 0.001 for combined group). Maximumworkload also
increased (101  37 vs. 119  41 W, p < 0.001 for the wholeand after exercise rehabilitation program for the whole group.
rogram
At identical work rate
p Before After p
0.9 0.015 e e e
2.03 0.006 e e e
0.10 0.014 2.13  0.59 1.93  0.58 0.001
7.3 0.008 47.8  3.4 46.3  2.6 0.002
5.0 ns 38.4  8.2 33.9  6.9 <0.001
0.11 0.058 1.59  0.39 1.58  0.38 ns
2.7 ns 61.1  17.2 53,6  16.3 <0.001
5.2 ns 32.2  5.5 36.2  6.7 <0.001
0.1/PImax %: mouth occlusion pressure/max inspiratory pressure %.
Figure 1 a. Error bar of P0.1 at rest before and after ERP in 46
patients with CHF. b. Error bar of P0.1/PImax at rest before and
after ERP in 46 patients with CHF.
Figure 2 a. Error bar of VT/TI at rest before and after ERP in
46 patients with CHF. b. Error bar of VT/TI at identical work-
load before and after ERP in 46 patients with CHF.
Figure 3 Error bar of PETCO2 at identical workload before
and after ERP in 46 patients with CHF.
Respiratory drive and interval training in CHF 1561group, 104 28 vs. 117 29 W for aerobic group, p< 0.001,
99  43 vs. 120  48 W for combined group, p < 0.001) as
well as VO2/t-slope (0.48  0.24 vs. 0.6  0.27 L min1
min1, p < 0.001 for the whole group, 0.49  0.24 vs.
0.57  0.25 L min1 min1, p Z 0.024 for aerobic group,
0.46  0.23 vs. 0.63  0.30 L min1 min1, p < 0.001), while
VE/VCO2 slope (31.5  6.0 vs. 30.3  5.5, p Z 0.14)
decreased but not statistically significantly. FEV1, FEV1%
predicted, FVC, FVC % predicted and FEV1/FVC, did not
change significantly after ERP. No differences were noted
regarding respiratory drive parameters and cardiopulmo-
nary parameters between the two groups of training. Both
improved P0.1, P0.1/PImax, VT/TI at rest, TI/TTot at rest and
VT/TI, fb, VE, PETCO2 at identical work rate as well as VO2 at
peak, VO2 at anaerobic threshold, VO2/t-slope, maximum
workload and VE/VCO2 slope following the ERP (Tables 3 and
4). Our patients show no difference in their weight and in
systolic and diastolic blood pressure at rest and at peak
exercise before and after the ERP.
There was no statistically significant difference at
baseline and 3 months after regarding respiratory drive
and cardiopulmonary parameters in the control group
(Table 5). Between the exercise group and the control
1562 A. Tasoulis et al.group there was a statistical significant difference in VO2
peak and P0.1/PImax at rest before and after 3 months of
follow up (Table 5).Discussion
This prospective study has shown that both types of
training, aerobic interval and interval plus strength training
improved respiratory drive and ventilatory pattern of
patients suffering from CHF, at rest and during exercise. To
our knowledge this is a novel study that evaluates the
effects of interval and combined exercise training on
respiratory drive in CHF patients.
The respiratory centers are stimulated by central
respiratory pacer cells, central and peripheral chemore-
ceptors, upper airway receptors, other areas of the brain,
pulmonary tension receptors, J receptors, and volitional
pathways. The signals are integrated to a single signal to
the respiratory muscles.34 The respiratory drive is a surro-
gate measure of this neural output, which controls the
ventilatory pattern.17 Respiratory drive, expressed as P0.1,
reflects both the neural output to, and the mechanical
response from, the inspiratory muscles.32 Its activation has
been studied in normal subjects and in patients suffering
from CHF. While it is used as an index of neural output to
the inspiratory muscles in normal subjects, absolute values
of P0.1 might underestimate the effective neural drive in
patients with inspiratory muscle weakness. Consequently,
the P0.1/PImax ratio is used as an index of central respiratory
output, normalized for inspiratory muscle strength.
Previous studies have observed a higher respiratory drive,
reflected by resting P0.1, P0.1/PImax and VT/TI ratio, in
patients with CHF compared to healthy controls, although
VT was similar at baseline.
17,35 Our study has shown
improvement in several respiratory drive parameters after
exercise in contrast with a previous study suggesting only
improvement in inspiratory muscle performance at
comparable submaximal workloads, probably due to
different exercise modality of training and the small
number of patients in that study.36Table 3 Respiratory drive and breathing pattern indices befor
group of patients.
Exercise rehabilitation p
At rest
Before After
P0.1 (cmH2O) 3.04  1.54 2.64 
P0.1/PImax % 4.27  3.0 3.33 
Mean inspiratory flow (l/s) 0.43  0.08 0.39 
Respiratory cycle (%) 46.3  6.9 47.3 
Breathing frequency (breath/min) 18.1  2.9 19.5 
Tidal volume (l) 0.64  0.11 0.58 
Minute ventilation (l/min) 11.7  2.5 11.1 
Partial pressure of end-tidal carbon
dioxide (mmHg)
34.7  4.7 35.1 
Values are means  SD.
P0.1: mouth occlusion pressure, 100 ms after the onset of inspiration, PExercise training improves several manifestations of
CHF, including neuro-hormonal, muscular and ventilatory
abnormalities, microcirculation and also increases exercise
capacity significantly.19,20,37,38 Our observations suggest
that ERP activated pathophysiological pathways, which
significantly lowered an abnormally high baseline respira-
tory drive. These changes caused significant decreases in
VT/TI, VE and fb at equivalent workloads. No difference was
observed in VT, indicating that the decrease in VE was
entirely attributable to a decrease in fb.
An excessive activation of the ergoreceptors has been
reported in patients presenting with CHF, along with
cachexia, autonomic abnormalities consistent with sympa-
thetic activation and vagal withdrawal, hemodynamic
abnormalities, and elevated plasma catecholamine concen-
trations.39,40 Therefore, the heightened sympathetic, vaso-
constrictor, and ventilatory drive characteristic of CHFmight
be partially explained by an exaggerated contribution of
ergoreflex during exercise. Physical training increases the
exercise capacity and partially reverses the abnormal
response to exercise by attenuating this reflex excitation.41
With ERP, the responses to the enhanced ergoreflex of
patients in CHF were brought to levels closer to those of
normal subjects. Although the mechanisms by which ERP
improves the pathophysiology of CHF are incompletely
understood, it is known to partially reverse early muscle
acidosis and muscle atrophy, lower cytokines levels, and
improve peripheral hemodynamic function. Improving
muscle function can attenuate the stimulus to the ergore-
flex, restoring a physiological balance.40 These pathophysi-
ological mechanisms might explain our observations.
Also neurohumoral activation, including activation of the
sympathetic nervous system, characterizes CHF and patients
with the greatest sympathetic activation have the poorest
survival. Muscle sympathetic nerve activity (MSNA) is proved
to be greater in heart failure patients compared with normal
controls, and exercise training results in dramatic reductions
in directly recorded resting sympathetic nerve activity.42 In
patientswith CHF and SleepApnea regular exercise improves
OSA severity and sleep architecture and reduces MSNA. It is
proposed that improvement in carotid chemoreflex control ise and after exercise rehabilitation program for the aerobic
rogram
At identical work rate
p Before After p
0.9 0.057 e e e
1.76 0.062 e e e
0.08 ns 2.2  0.56 2.02  0.55 0.006
6.3 ns 48.3  3.4 46.9  2.3 0.066
3.6 ns 38.1  7.8 35.1  8.1 0.004
0.12 0.011 1.67  0.28 1.62  0.30 ns
2.3 ns 63.2  15.0 56.7  15.7 0.03
5.8 ns 32.0  5.8 35.0  6.3 0.16
0.1/PImax %: mouth occlusion pressure/max inspiratory pressure %.
Table 5 Cardiopulmonary exercise testing and respiratory drive indices before and after 3 months of follow up of both
exercise training and control group.
Exercise group Control group
Before After Before After p (Between
groups)
Respiratory drive parameters at rest
P0.1 (cmH2O) 3.04  1.52 2.62  0.9** 2.62  0.82 2.71  0.9 ns
P0.1/PImax % 4.56  3.73 3.69  2.03** 3.1  1.5 3.3  2.1 0.045
Mean inspiratory flow (l/s) 0.44  0.10 0.41  0.10** 0.46  0.13 0.48  0.17 0.09
Respiratory cycle (%) 43.9  6.1 45.9  7.3** 45.4  5.4 44.4  6.9 ns
Breathing frequency
(breath/min)
19.5  4.4 19.6  5.0 20.9  3.5 20.4  3.9 ns
Tidal volume (l) 0.60  0.11 0.57  0.11* 0.62  0.14 0.6  0.12 ns
Minute ventilation (l/min) 11.4  2.8 11.1  2.7 12.3  2.6 12.5  3.2 ns
Partial pressure of end-tidal
carbon dioxide (mmHg)
34.3  4.5 35.4  5.2 31.8  4.5 31.6  3.7 ns
Cardiopulmonary exercise testing parameters
VO2 at peak exercise
(ml/kg/min)
16.3  4.8 18.5  5.3* 15.8  5.9 16.4  6.5 0.05
VE/VCO2slope 31.5  6.0 30.3  5.5 34.7  9.5 35.3  8.3 ns
Mean inspiratory flow (l/s) at
peak
2.13  0.59 2.4  0.7* 2.07  0.8 2.12  0.74 0.069
Respiratory cycle (%)at peak 47.8  3.4 48.2  3.0 44.7  3.0 46.3  2.8 ns
Breathing frequency (breath/
min) at peak
38.4  8.2 40.6  6.8** 34.6  8.2 35.0  6.0 ns
Tidal volume (l) at peak 1.59  0.39 1.73  0.43* 1.6  0.56 1.64  0.54 0.077
Minute ventilation (l/min) at
peak
61.1  17.2 70.5  21.6* 55.8  23.1 57.7  22.4 0.08
Partial pressure of end-tidal
carbon dioxide (mmHg) at
peak
32.2  5.5 32.1  6.2 31.7  5.9 31.9  5.1 ns
Values are means  SD.
P0.1: mouth occlusion pressure, 100 ms after the onset of inspiration, P0.1/PImax %: mouth occlusion pressure/max inspiratory pressure %.
Comparison within group analysis. *p < 0.001, **p < 0.05.
Table 4 Respiratory drive and breathing pattern indices before and after exercise rehabilitation program for the combined
group of patients.
Exercise rehabilitation program
At rest At identical work rate
Before After p Before After p
P0.1 (cmH2O) 3.04  1.53 2.59  0.92 ns e e e
P0.1/PImax % 4.84  4.37 3.98  2.21 0.099 e e e
Mean inspiratory flow (l/s) 0.45  0.12 0.41  0.12 0.052 2.06  0.61 1.86  0.6 0.031
Respiratory cycle (%) 41.8  4.5 44.7  8.0 0.011 47.4  3.4 45.8  2.7 0.011
Breathing frequency
(breath/min)
20.7  5.1 19.6  6.0 ns 38.6  8.6 32.9  5.6 0.003
Tidal volume (l) 0.57  0.11 0.57  0.12 ns 1.53  0.46 1.55  0.44 ns
Minute ventilation (l/min) 11.3  3.2 11.1  3.0 ns 59.4  18.9 51.0  16.6 0.006
Partial pressure of end-tidal
carbon dioxide (mmHg)
34.0  4.3 35.6  4.6 0.071 32.3  5.3 37.3  6.9 0.001
Values are means  SD.
P0.1: mouth occlusion pressure, 100 ms after the onset of inspiration, P0.1/PImax %: mouth occlusion pressure/max inspiratory pressure %.
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1564 A. Tasoulis et al.implicated in this exercise training benefit. Since chemo-
reflex control integrates in the central nervous system (CNS),
it is reasonable to conclude that exercise leads to changes in
the CNS that may affect respiratory drive.43
Another significant finding was the improvement of
PETCO2 after ERP which is an indirect index of ventilator
efficiency. Furthermore, the ventilatory response to exer-
cise as assessed by VE/VCO2 slope, a significant prognosis
indicator that also reflects interstitial pulmonary edema
demonstrated a trend to improve.44
In patients with Chronic Obstructive Pulmonary Disease
(COPD) the degree of exertional dyspnea correlates with
resting respiratory drive and at similar mechanical load and
similar levels of respiratory muscle dysfunction, dyspnea
may result from an individual’s response of the central
motor output.45 These data support the concept that exer-
tional dyspnea is modulated by afferent output from central
receptors. In patients with COPD the beneficial effect of
exercise training in increasing aerobic capacity, neuromus-
cular coupling of the ventilatory pump, yielding significant
adaptations in the muscles and contributing to the relief of
both exertional dyspnea is well established.46,47
Although there was no statistical difference between
the two types of exercise training it seems that combined
training improves respiratory cycle and PETCO2 at rest and
at identical work rate more than interval training alone
suggesting that the greater peripheral muscle stimulation
might induce beneficial effects in peripheral chemorecep-
tors activity, and endothelial function in CHF patients;
however the small number of patients enrolled in this study
limits the comparison of the two types of training.
Clinical implications
P0.1, P0.1/PImax and VT/TI seem to be among the few vari-
ables measurable at rest, which improved after ERP. It also
seems that interval exercise training alone or with the
addition of resistance training not only improves exercise
capacity but also partially reverses respiratory drive
abnormalities during exercise in chronic heart failure
patients. Our study also implies that exercise training
modulates chemosensitivity and minimizes the output of
these central receptors potentially benefiting patients with
chronic heart failure. The reliability of these parameters as
a means of evaluating therapeutic interventions in these
patients merits further investigation.
Study limitations
Comparison of the two groups of training did not demon-
strate differences regarding respiratory drive and cardio-
pulmonary parameters due to the small number of
participants. The power analysis for the comparison of the
two training groups showed that the study was underpow-
ered. Definite conclusions for the possible different effects
of the two types of training on respiratory drive cannot be
deduced by the present study. A limitation of the study is
also that we did not use a specific questionnaire in order to
measure and monitor the patients’ daily activity.
Another possible criticism of the present study is the
controversial use of P0.1 to measure central drive inpatients with CHF and coexisting COPD as P0.1 is influenced
by hyperinflation and by resistive and elastic loads, factors
that lead to P0.1 underestimation.
33
In conclusion, a 3-month supervised ERP by interval
exercise training alone or with the addition of resistance
training improves the respiratory drive and the ventilatory
pattern at rest and during exercise in CHF patients.
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